Managing Consultant & Founder of the MGC Consulting Services company – Member of KEMEL NGO
Ex Coordinating Medical Director Janssen EMEA Mid-sized Markets
Janssen EMEA MSL Council Chairperson
Member of the MSM LT and the EMEA MEDICAL AFFAIRS LT
Katerina Papathoma has undertaken the mentoring of the teams MaGOS and BIOPIX – T. Her strong experience from the pharmaceutical industry as also her passion with volunteering has helped the teams from day one to define goals and parameters that are suitable within their company’s culture and commercialization goals.
She has managed to build a very functional relationship with the teams and therefore to successfully assist their development by assisting them to:
1. Determine their goals – clearly identify what should be achieved, how achievements are tied to business objectives, and how to measure success
2. Choose the right people according to the company’s need and its future success
3. Develop a clear action plan, since an effective program begins with defined objectives.
4. Reach the proper end users and business developers given the duration of each project in a very effective manner
Organization of bootcamps and regular training sessions is an integral part of the mentorship with the support of the other expert members of KEMEL
As Managing Consultant of MGC Consulting Services she provides support and consultation in the areas of her expertise: pharma research & development, regulatory, compliance and medical affairs.
Chemist of University of Athens, holding a Pharmaceutical Physician Diploma from the Basel University, Switzerland and having 20-years of working experience as Director of Medical, Scientific and Drug Quality and Regulatory Affairs.
Experienced in working with the local Health Authorities having worked with IFET (National Institute for Pharmaceutical Research) and EOF (National Medicines Organization) (1989-1992) and various multinational pharma companies. In 1992 she joined Cilag / Pharmaceutical Division of J&J Hellas, as Scientific Affairs Manager and later on, as Medical Director. In 1997 she joined ROCHE HELLAS as Head of Drug Regulatory Affairs. In 1999, she joined the Janssen- Cilag Pharmaceutical SACI as Medical Affairs Director, position that she holds until today.
Experienced in leading international teams and functions (2006- 2010) as Pharmacovogilance South Area Head and QMS Coordinator for ESEM (Europe South East Middle East).
From November 2015 until December 2018, she was the Coordinating Medical Director for the Mid-sized Markets (MSM) of Janssen and the EMEA MAF Disclosure Leader. In this critical role she was driving Medical Affairs excellence across MSM countries having the oversight and coordination of the respective MAF functions. She represented the MSM countries in the EMEA Medical Affairs Leadership Team and coordinated the RWE initiatives with HEMAR and other involved functions.
She led various EMEA MAF initiatives like MAF MAX 2020 Physician engagement initiative and the MSL Keystone project.
She is member of KEMEL, and Mentor in a number of research based start up teams. She was elected President of the Hellenic Association of Pharmaceutical Physicians for 6 consecutive years (June 2011- June 2017).